Bronchial hyperreactivity in allergic and non-allergic rhinitis compared to allergic and non-allergic asthma

HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.

American heart journal·2026

Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa.

Open forum infectious diseases·2024

The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes.

Arthritis research & therapy·2024

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

European heart journal·2021

Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients.

Scandinavian journal of rheumatology·2021

Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021